Background: Head and neck Magnetic Resonance (MR) Images are vulnerable to the arterial blood in-flow effect. To compensate for this effect and enhance accuracy and reproducibility, dynamic tracer concentration in veins was proposed and investigated for quantitative dynamic contrast-enhanced (DCE) MRI analysis in head and neck.
Introduction
Angiogenesis is vital for the growth and metastasis of malignant tumors. Dynamic contrast-enhanced (DCE) MRI is a valuable non-invasive imaging method that enables the investigation of tissue microvascular environment for many clinical oncology applications. To conduct DCE-MRI, paramagnetic gadolinium based contrast agent, also called tracer, is administrated and passes through the capillary bed where it leaks into the extravascularextracellular space (EES). This leakage process is influenced by factors like the blood flow, permeability and surface area of the microvessels as well as the volume of EES. The accumulation of tracer concentration in the EES induces longitudinal relaxation time (T1) shortening effect and leads to image intensity enhancement when acquired by T1-weighted MRI pulse sequences. By dynamically monitoring the MR signal variation with time before and after tracer administration, information on the microvascular structure and function could be derived through the subsequent pharmacokinetic analysis on the dynamic image series. DCE-MRI is now playing a more important role in clinical oncology applications such as cancer characterization [1] , treatment evaluation [2] and development of anti-angiogenic and vascular-targeting drugs [3] , including for those cancers that are located in head and neck [4] [5] [6] [7] [8] [9] [10] . Although DCE-MRI could be analyzed semi-quantitatively to derive heuristic parameters like maximum enhancement intensity and rate, and the area under dynamic curve, quantitative DCE-MRI analysis based on pharmacokinetic models [11, 12] is able to retrieve physiologically relevant parameters that are independent of scanner and imaging protocols, and hence holds the potentials for standardized multicenter data comparison and clinical trial study.
For most pharmacokinetic models, the measurement of arterial input function (AIF), i.e. the dynamic tracer concentration in the arterial blood plasma, is essential. The accurate measurement of the AIF remains one of the major challenges that hamper the reproducibility of DCE-MRI kinetic analysis and the widespread acceptance of DCE-MRI into clinical practice [13] [14] [15] . AIF is a complicated function which is influenced by many technical factors (including spatial and temporal resolution, dose and rate of tracer injection, accuracy of the T1 measurements, in-flow effect, partial volume effect, and B1 inhomogeneity [16] [17] [18] ) and many patient-related factors (including heart output rate, vascular tone, hematocrit, tracer distribution in the body and kidney function). In the head and neck there are additional patient-related factors that are impediments to accurate AIF measurement. These factors include tissue susceptibility effects, motion artifacts due to blood pulsation and swallowing, and vascular disease such as atherosclerosis which may cause narrowing and turbulent flow in the artery.
This study proposes to overcome some of the difficulties of measuring the AIF by measuring the dynamic tracer concentration in the jugular veins rather than in the carotid arteries, in order to alleviate the influence of in-flow effect and provide a larger caliber vessel which is less prone to disease for head and neck DCE-MRI analysis. The tracer concentration measurement in veins has been adopted in some brain perfusion studies, where the measurement of venous output function (VOF) in the superior sagittal sinus [19, 20] has been used to reduce partial volume effect, but to the best of our knowledge veins have not been utilized in the neck.
In DCE-MRI, in-flow effect manifests as a signal enhancement due to the flow of fully-polarized fresh blood into the imaging volume and results in both a strong increase in the absolute signal intensity and a significant reduction in the dynamic range of contrast enhancement [21] . Moreover, in-flow effect also induces the errors for in vivo blood T1 measurement and hence is considered as a major confounding factor of the AIF measurement [17] . In-flow effect is dependent on many factors, including the tracer concentration, blood flow velocity, slice location, as well as imaging parameters like flip angle, TE and TR, so is difficult to be precisely modeled and completely compensated. Advanced in-flow correction methods have been proposed [21, 22] , however, they are still rarely applied in DCE-MRI data acquisition due to the extra scan time, the complicated calibration, and the inherent unsteadiness of blood flow in arteries.
Blood plasma could be considered as a single pool for high velocity flows with low permeability between the plasma and the extra-vascular space [12] . The major organ between the arterial and venous circulation in the head and neck is the brain, which as a result of the blood brain barrier (BBB) has a low permeability. In addition the blood travel time between carotid arteries and jugular veins is short. Therefore, tracer concentration in jugular veins and carotid arteries is assumed to be nearly equal within this short time delay. Upon this presumption, the use of contrast agent concentration in the jugular veins could greatly alleviate the inflow effect in that the blood flow velocity in the jugular veins (1863 cm/s) [23] is much slower than that in the carotid arteries (maximum systolic 108.263.8 cm/s, cycle-averaged 38.861.5 cm/s) [24] . Meanwhile, blood in the jugular veins flows more steadily during the heart cycle with less pulsation. Unlike population-averaged AIF [25] , this method allows the direct measurement on each individual subject and respects the underlying inter-individual variation in physiology and the tracer injection protocol differences. Compared to other approaches, this method is convenient and the measurement accuracy of tracer concentration in the vein is robust to slice locations and less susceptible to T1 measurement errors. Compared to some advanced in-flow correction methods [21, 22] , no complicated calibration and correction algorithm and extra scan time are required either. Therefore measurements obtained from the jugular vein could be applied quite straightforwardly using the existing kinetic DCE-MRI analysis tools by clinicians and potentially. This method would benefit multicenter cross-sectional studies by standardizing the AIF measurement in head and neck after validation by more clinical studies.
Results
Primary tumors were identified from anatomical TSE images and their sites were supraglottic (n = 6), oropharynx (n = 9), hypopharynx (n = 5), and buccal mucosa (n = 1). Primary tumor sizes ranged in maximum axial diameter from 10 mm to 52 mm (mean = 37 mm). The corresponding areas ranged from 18 mm 2 to 1123 mm 2 (mean = 456 mm 2 ). Twelve metastatic nodes were also identified with sizes ranged in minimum axial diameter from 15 mm to 37 mm, mean = 27 mm (area from 219 mm 2 to 1165 mm 2 , mean = 583 mm 2 ). Arteries and veins were well separated by the automated method in all patients and manually confirmed by the radiologist. Figure 1a shows the labeling of arteries and veins on an image slice of one patient, in which red spots labels artery voxels and green spots labels vein voxels. Boundary voxels around vessels were excluded automatically to remove the partial volume effect. The isolated vertebral artery voxel (yellow arrow), was also excluded due to its proneness to partial volume effect. For all patients, the result showed that artery voxels primarily came from the carotid arteries and vein voxels primarily came from the jugular veins because of their large cross section areas. Figure 1b shows the dynamic peak times for artery and vein voxels in the image slices. The square marker denoted the average peak time value and the error bar denoted the standard deviation of the peak time for artery and vein voxels for each slice. It is shown that the average peak time of arteries appeared about 7.5 s earlier than veins. The peak times and the time delays in arteries and veins were stable for slices.
The averaged dynamic ITCs for artery voxels and vein voxels for each image slice were shown in Fig. 2a and 2b respectively. Pronounced inter-slice differences in baseline intensity, peak intensity and wash-out level were found for artery voxels, while the dynamic ITCs for vein voxels were quite consistent between slices. Figure 2c illustrates the baseline and peak intensities in arteries and veins. The baseline intensity in arteries decreased approximately by a factor of two from the most inferior slice 8 to the superior slice 18. In contrast, the baseline intensity remained quite stable in veins within all slices.
The blood in-flow effect on the measured T1 values for artery and vein voxels were illustrated in Fig. 3 , which also explain the motivation of using literature values of blood T1 for analysis. Measured T1 values in the artery voxels increased with the ascending slices. For vein voxels, T1 values were relatively stable (mean 1120 ms) between slices. The in-flow effect severely compromised the T1 measurement accuracy in arteries, while its effect on venous blood T1 measurement was relatively moderate. The large standard deviation of T1 measurement could be explained by partial volume effect, non-uniform intra-vessel blood flow speed, as well as the dual-flip-angle limitation.
Large variability of dynamic concentration in arteries (based on ITCs in Fig. 2 ) was found between slices even if the constant literature T1 value was used, as shown in Fig. 4a . As comparison, relatively consistent dynamic CTCs were achieved in the vein voxels (Fig. 4b) . The slice-averaged dynamic CTCs in arteries and veins were shown in Fig. 4c along with the time shifted CTC in veins with the peak time aligned to the peak time in arteries. The peak concentration of the averaged vein CTC was about three times higher than that of artery CTC, which was underestimated due to the fast arterial blood flow.
For voxel-wise fitting within the lesion ROIs, around 7-24% of total voxels for different subjects failed of fitting due to the violation of fitting restrictions or the poor goodness of fit when arterial CTCs were used, while the corresponding voxel fraction was reduced to 3-15% by using venous CTCs. The successfully fitted pixels had the average goodness of fit R 2 of 0.84 and 0.89 for all lesions by using arterial and venous CTCs, respectively. These results indicated that the Tofts model fitting by using venous CTCs was more robust and less vulnerable to the noise and signal fluctuations. Representative Tofts parameter maps within a metastatic node ROI (overlaid on the first time point pre-contrast DCE image) by using the slice-averaged dynamic CTCs in arteries and veins were illustrated in Fig. 5 .
The fitting results by using the slice-averaged dynamic CTCs in arteries and veins were compared by bar plots for primary tumors (n = 21) in Fig. 6a and for metastatic nodes (n = 12) in Fig. 6b . All pharmacokinetic parameters were expressed as slice and voxel averaged values within the primary tumor and metastatic node ROIs by the bar heights in Fig. 6 . Except for k ep (p = 0.081 for primary tumors, p = 0.093 for metastatic nodes, paired student's ttest), significant differences were found in the estimated K trans , v e and v p by using the dynamic CTCs in arteries and veins (p,0.01 for both primary tumors and metastatic nodes, paired student's ttest). The estimated K trans , v e and v p by the use of dynamic CTCs in arteries were generally around 3-3.5 times larger than the corresponding estimations by the use of CTCs in veins.
Tofts parameter fitting results (slice and voxel averaged value) on a primary tumor by using individually extracted CTCs for each slice ( Fig. 4a and 4b ) were compared to the fitting results by using the averaged CTCs (Fig. 4c) . Fig. 7a shows the percent deviations induced by the use of the extracted CTCs in arteries for each slice relative to the reference of the fitting results using the sliceaveraged CTC in arteries. The fitting results considerably varied compared to the reference. Large deviations over 50% were found in the estimations of K trans , v e and v p , especially by the use of CTCs from the inferior slices (slices [8] [9] [10] [11] [12] . ANOVA analysis showed that K trans , v e and v p derived from the individual CTCs of each slice were generally significantly different (p,0.01) from the reference (except for a smaller number of cases such as v p derived from the CTC of slice 9 and v e derived from the CTC of slice 14), while k ep showed no significant difference. As comparison, the fitting results by using the individual CTCs in veins (Fig. 7b) were much more stable and consistent compared to the reference by using the slice-averaged CTC in veins. The fitting deviations were all smaller than 35% for estimations of all physiological parameters. Generally, no significant differences in kinetic parameter estimation were found by the use of vein CTCs from each individual slice compared to the reference except for a small number of cases, for example, K trans and v e derived by the CTC of slice 13, which may be attributed to the relatively low SNR of the images or the tissue heterogeneities.
Discussion
In physiology, arteries are usually the feeding vessels to capillaries and the dynamic tracer concentration in arteries should be used for pharmacokinetic modeling. In opposition, veins are usually blood draining vessels from capillaries that reflect blood outflow from tissues. However, the dynamic tracer concentration in veins can be considered equal to that in arteries for a single blood-pool and low permeability model between the plasma and the extra-vascular space. For head-and-neck DCE-MRI, this assumption can be satisfied because the major tissue, brain, in between the blood flow pathway normally has low permeability. Meanwhile, the transport of tracer out of the vasculature and hence the depletion of intravascular concentration may also be negligible due to the small tracer bolus arrival time difference in carotid arteries and jugular veins. However, the depletion of intravascular concentration is still difficult to be validated by clinical means and should be further investigated in the future. It is also worth pointing out that the applicability of the proposed method may not be generalized to other tissues like liver, and to patients with compromised BBB, where the shape of the venous CTC can be substantially modulated by contrast agent exchange along the blood flow pathway. The presented approach could also introduce some insecurities such as a variable transit time through the brain. In particular, intracranial masses such as metastases or meningeomas or sinus thrombosis may affect the venous outflow. Under these conditions, the reliability of the venous CTC may be compromised and has to be further addressed in future studies.
It is worth noting that the measured much shorter of T1 in arteries primarily attributed to the in-flow effect rather than the uncertainty induced by the dual-flip-angle method [16, 17] . The adoption of literature arterial blood T1 values of 1550 ms might yield the under-estimation of AIF. However, Tofts parameter estimation deviation induced by the limitation of dual-flip-angle method [26, 27] would not result in biased physiological parameter estimation comparison between using the dynamic tracer concentration in arteries and veins.
Given the high temporal resolution of 2.59 s in this study, not only time shift between arterial and venous concentrations, but also contrast agent dispersion could be observed, reflected by a slower increase to peak for venous concentration curves (Fig. 4c) . However, the broadening of the first bolus peak in veins by dispersion was observed small due to the low tissue permeability along the blood flow pathway and the short delay of bolus arrival. In spite of this small dispersion, its effect on kinetic parameter estimation should be further investigated in future studies.
As seen in Fig. 4 , there were still noticeable inter-slice differences of venous CTC curves (Fig. 4b) , although much smaller than those of arterial CTC curves (Fig. 4a ). This could be partially explained by the presence of venous blood flow. Although its velocity is much slower than that in arteries, it could still induce similar (but smaller) variability as in AIF extraction. In this respect, similar flow correction methods employed for AIF extraction may also be applicable for the further reduction of venous CTC variations.
The use of the averaged CTCs in arteries and veins for Tofts model generated remarkably different parameter estimation results (Fig. 6 ) except for k ep . The similarity in k ep estimation was because that k ep was primarily determined by the tissue CTC shape (k ep only appears inside the integral item, which determines the dynamic curve shape, as an independent parameter to be fit in Eq. 2) rather than the absolute concentration values according to the Tofts modeling [12] . As seen in Fig. 4 , the slice-averaged arterial and venous CTC after time shift had very similar shape pattern but just majorly differed on the absolute concentration value, so it was expectable that their derived k ep values should be close. It was interesting to find that K trans and v e values derived from artery CTC were closer to the literature reported values in the literature [10] . This observation could be explained since the method in this literature was quite similar to our method by using the artery CTC, without accounting for in-flow effect in arteries. However, we considered that the parameter estimation using the vein CTC should be more reliable due to the lower in-flow contamination.
This study only investigated the DCE-MRI quantification at a fixed tracer dose administration of 0.1 mmol/kg of body weight. This dose is recommended by the Imaging Committee of the Experimental Cancer Medicine Centres (ECMC) for the standardization of DCE-MRI acquisition and quantification [28] . In principle, pharmacokinetic parametric mapping should be independent of tracer dose. In practice, the dose of tracer may affect DCE-MRI signal enhancement level and hence slightly affect the accuracy and uncertainty of quantification results. The report on the optimized tracer dose for better DCE-MRI quantification is still sparse [29] and may need to be further explored. The lack of reproducibility study is another limitation of this study due to the scope of the current ethical approval. The comparison of reproducibility of pharmacokinetic quantification by using arterial and venous CTC is of importance and needs to be conducted in the future. Nonetheless, the current study showed that the goodness of fit by using the venous CTC was better than that by using the arterial CTC, indicating the advantage of more reliable and robust fitting in mathematics and less proneness to noise and signal fluctuations by using the venous CTC.
In conclusion, the use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck was proposed and presented to compensate for the severe in-flow effect caused by the fast and pulsatile blood flow in arteries. More reliable and consistent parameter estimations based on Tofts model could be achieved by using the vein CTCs compared to artery CTCs.
Materials and Methods

Ethics Statement
Ethical review board approval was obtained for DCE-MRI exam and data analysis. Patients and MRI Experiment MR imaging was performed on 21 patients (3 females, 18 males, mean age 57.5 years) with untreated HNSCC who had no previous history of a head and neck cancer. Informed consent was obtained before the DCE-MRI examination.
All DCE-MRI scans were performed on a 3T Philips Achieva MRI scanner (Philips Medical Systems, Best, The Netherlands) using a 3D spoiled gradient echo sequence. Body coil was used for excitation and a 16-channel head and neck array coil was used as signal receiver. Imaging parameters for DCE-MRI included: TR/ TE = 3.9 ms/0.9 ms, flip angle = 15u, FOV = 230 mm6230 mm6100 mm, matrix = 1286128625, voxel size = 1.8 mm61.8 mm64 mm, SENSE factor = 4. 185 dynamic images for each slice were acquired at a temporal resolution of 2.59 seconds with a total DCE-MRI scan time of around eight minutes. Contrast agent (CA) injection was performed in the form of a bolus injection of Gd-DOTA (Dotarem, Guerbet, France) at a concentration of 0.1 mmol/kg of body weight, using a power injector pump (Medrad, Pittsburgh, Pa) through a 21-gauge intravenous catheter in the right antecubital vein. The injection rate was set at 2.5 mL/s, followed by a 20-ml saline flush at the same injection rate. The CA injection started at six seconds after the commencement of dynamic image acquisitions. Prior to the dynamic image acquisitions, a baseline image for each slice was acquired with the identical imaging parameters as DCE acquisition except a flip angle of 7u was used. T1 maps were calculated from the baseline images and the precontrast images using the dual-flip-angle method (7u and 15u) [30] . Immediately after the DCE-MRI scan, anatomical images were acquired as part of our routine clinical scan using a 3D turbo spin echo (TSE) sequence (TE/TR = 10 ms/620 ms, Turbo factor = 4, FOV = 230 mm6180 mm6200 mm, voxel size = 0.55 mm60.79 mm64 mm, SENSE factor = 1.5, number of signal average NSA = 2).
DCE-MRI Analysis
DCE-MRI dynamic images were exported and processed offline using in-house Matlab (The MathWorks, Natick, MA, USA) programs.
Only the central eleven inner slices within the imaging slab were used for vessel extraction to remove the inhomogeneous inter-slice B1 excitation profile for outer slices. An automated vessel voxel extraction method was used [31] [32] [33] and briefly described here. The average maximum dynamic intensities for all voxels (S max-avrg ) except for the background were calculated. Then, a voxel was labeled as a vessel (artery or vein) voxel if its maximum intensity was greater than S max-avg plus three times the standard deviation (SD) of S max-avrg . Artery voxels were separated from vein voxels according to the time of the maximum intensity (peak time). The isolated single vessel voxels were removed because they were prone to partial volume corruption. The average signal intensities of the artery and vein voxels were calculated to create the signal ITCs. Signal ITCs were then converted into the plasma concentration C p (t) according to
where S Gd (t) and S 0 denote post-contrast image intensity at time t and pre-contrast baseline image intensity, respectively. r 1 is the tracer relaxivity (,4.5 s 21 mM
21
). T 10 is the pre-contrast intrinsic T1 relaxation time. C b (t) and C p (t) denote the tracer concentration in blood and plasma respectively. Hct is hematocrit and assumed to be 0.42. Extended Tofts model was applied for estimation of physiological parameters [25, 34] C tis (t)~v p C p (t)zK
where C tis (t) is the concentration of contrast agent in the tissue at time t, estimated by the relative signal enhancement method similar to Eq. 1 and C tis (t)~(S tis (t){S tis0 )=(r 1 : T tis10 S tis0 ). K trans , k ep , v e , and v p denote volume transfer constant, rate constant between blood plasma and extravascular-extracellular space, the volume fraction of EES and volume fraction of plasma, respectively.
To compensate the in-flow induced T1 underestimation and the measured inter-slice T1 variation [17, 21] , literature T1 values of 1550 ms [35] for arterial blood and 1852 ms [23] for venous blood at 3T were adopted for the conversion of blood ITCs to CTCs, respectively.
Before the use of venous plasma C p (t) for Tofts model fitting, the venous CTC was shifted forwardly in time based on the peak time difference to account for the time delay between veins and arteries, accomplished in discrete steps given by the temporal resolution without interpolation because the acquisition temporal resolution was sufficiently high.
Primary tumors and metastatic nodes were identified and outlined on the anatomical MR images by a radiologist with over 15 years' experience in head and neck MR imaging. Voxel-byvoxel fitting to Eq. 2 was performed for regions-of-interest (ROIs) of primary tumors as well as metastatic nodes within the central eleven inner slices from which the CTCs were estimated. Three independent parameters of k ep , K trans , and v p were derived by non-negative least squares fitting based on Levenberg-Marquardt algorithm. The lower and upper limit of v p for fitting were set as zero and one. The upper limit for k ep fitting was set as three, sufficiently high to reveal the high vascularity of tumors and glands (such as salivary glands) in head and neck tissues. K trans was constrained to be smaller than k ep . The sum of v p and v e were constrained to be smaller than one. Voxels that failed of fitting due to the violation of fitting restrictions or associated with the goodness of fit (R 2 ) smaller than 0.8 were counted and excluded from the further analysis. Paired student's t-test was performed to compare the fitting results by using the CTCs in arteries and veins. Consistency and variability of the extracted kinetic parameters by using the individual CTCs from each slice were compared to the reference levels by using the slice-averaged CTCs of arteries and veins with one-way analysis of variance (ANOVA) and TukeyKramer method. P-values less than 0.05 were considered statistically significant. Note that the reference defined here by using the slice-averaged CTCs were only used as the comparison baseline but did not necessarily indicate the gold standard for higher accuracy of parameter estimation. 
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